×

Analyzing Eli Lilly's drug pipeline

10:15 AM ET Mon, 12 Jan 2015

CNBC's Meg Tirrell speaks to John Lechleiter, Eli Lilly CEO, about the strength and outlook for the health care sector, and what new drugs he's most excited about.